ERCC overexpression associated with a poor response of cT4b colorectal cancer with FOLFOX‑based neoadjuvant concurrent chemoradiation-Reference-Cited by-同舟云学术

ERCC overexpression associated with a poor response of cT4b colorectal cancer with FOLFOX‑based neoadjuvant concurrent chemoradiation

Published:2020-09-08 Issue:5 Volume:20 Page:1-1
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Huang Ming-Yii¹^ORCID,Lee Hsin-Hua¹,Huang Ching-Wen²,Huang Chun-Ming ¹,Ma Cheng-Jen²,Yin Tzu-Chieh²,Tsai Hsiang-Lin²,Chai Chee-Yin ³,Chen Yi-Ting³,Wang Jaw-Yuan⁴^ORCID

Affiliation:

1. Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.

2. Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.

3. Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, R.O.C.

4. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer;Cells;2022-11-23

2. ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells;Cancers;2022-09-30

3. Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma;International Journal of Molecular Sciences;2022-07-28

4. Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy;Cells;2022-05-11

5. Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer;PLOS ONE;2021-11-02